← All companies
VERTEX PHARMACEUTICALS INC / MA
VRTX - CIK 0000875320
Market cap$110.46 B
Rank#136
SEC filings1,000
The table below shows VERTEX PHARMACEUTICALS INC / MA's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.49B | $4.94B | $4.97B | $4.67B | $5.24B | $4.58B |
| Short-term investments | $1.75B | $1.35B | $1.41B | $1.53B | $1.29B | $1.22B |
| Receivables | $2.00B | $1.95B | $1.89B | $1.81B | $1.75B | $1.66B |
| Inventory | $1.77B | $1.63B | $1.50B | $1.36B | $1.08B | $914.60M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.